Duke University: The Fuqua School of Business
100 Fuqua Drive
Durham, NC 27708
George B. Abercrombie served as President and Chief Executive Officer at Hoffmann-La Roche Incorporated from 2001-2009 where he was responsible for leading the North American Pharmaceuticals Operations in Nutley, New Jersey, and the Canadian affiliate, Hoffmann-La Roche Ltd. in Mississauga, Ontario. During his tenure, Abercrombie also served as a member of the Roche Pharmaceutical Executive Committee (PEC), which was responsible for developing and implementing global strategy for the Pharmaceuticals Division. While at Roche, Abercrombie was a member of the Executive Committee and Board of Directors of the U.S. trade organization PhRMA (Pharmaceutical Research & Manufacturers of America), and the state Healthcare Institute of New Jersey.
Before joining Roche, Abercrombie was Senior Vice President of U.S. commercial operations at Glaxo Wellcome, with responsibilities encompassing pharmaceutical sales and marketing, electronic commerce, the U.S. managed care system, disease management, business planning and development, and late-stage clinical drug studies. He joined Glaxo as Vice President and General Manager of the Glaxo Pharmaceuticals Division in 1993 following 10 years at Merck, where he held a broad range of positions in sales, marketing, executive sales management and business development.
Abercrombie began his career as a pharmacist after receiving a bachelor’s degree in pharmacy from the University of North Carolina at Chapel Hill. He later earned an MBA from Harvard University. In July 2010, he attended the Harvard Business School course, Making Corporate Boards More Effective.
Abercrombie is currently Senior Vice President and Chief Commercial Officer at Innoviva, Inc. He serves on the Board of Directors of Biocryst Pharmaceuticals where he is a member of the Audit and Corporate Governance and Nominating Committees. Additionally, he is a member of the Board of Directors of Brickell Biotech, serving on the Compensation Committee.
As an Adjunct Professor at Duke University’s Fuqua School of Business, Abercrombie teaches second year MBA candidates in Fuqua’s Health Sector Curriculum.
Abercrombie is a member of the Board of Directors of the North Carolina GlaxoSmithKline Foundation and is an Inaugural Member of the Duke University Psychiatry and Behavioral Sciences Advisory Board. As President of Abercrombie Advisors LLC, Abercrombie has consulted to early and mid-stage biopharmaceutical companies.